Aman, Angelita .
HRN: 10-00-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
CEFTRIAXONE 1G (VIAL)
05/04/2026
05/11/2026
IV
2G
Q24
CKD/UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: